Madrigal Pharmaceuticals, Inc. MDGL Convertible Preferred Stock Issued Shares
Convertible Preferred Stock Issued Shares at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesIssued.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s convertible preferred stock issued shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s convertible preferred stock issued shares?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported convertible preferred stock issued shares of 2.4M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s convertible preferred stock issued shares changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s convertible preferred stock issued shares decreased by 0.0% year-over-year, from 2.4M to 2.4M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s convertible preferred stock issued shares?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s convertible preferred stock issued shares has grown at a 3.8% compound annual growth rate (CAGR), from 2M to 2.4M.
- What does convertible preferred stock issued shares mean?
- The total number of convertible preferred shares the company has issued.
- How do you interpret convertible preferred stock issued shares?
- Provides context on the total capital structure and the extent of preferred equity financing utilized.
- How does convertible preferred stock issued shares compare across companies?
- Used to compare the capital structure complexity across different biopharmaceutical companies.